KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) Invested Capital (2016 - 2025)

Historic Invested Capital for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $2.6 billion.

  • Repligen's Invested Capital rose 16.54% to $2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 16.54%. This contributed to the annual value of $2.5 billion for FY2024, which is 259.51% down from last year.
  • Latest data reveals that Repligen reported Invested Capital of $2.6 billion as of Q3 2025, which was up 16.54% from $2.1 billion recorded in Q2 2025.
  • Over the past 5 years, Repligen's Invested Capital peaked at $2.6 billion during Q3 2025, and registered a low of $1.6 billion during Q1 2021.
  • Its 5-year average for Invested Capital is $2.1 billion, with a median of $2.0 billion in 2023.
  • As far as peak fluctuations go, Repligen's Invested Capital skyrocketed by 5248.56% in 2021, and later tumbled by 2129.11% in 2025.
  • Repligen's Invested Capital (Quarter) stood at $1.8 billion in 2021, then rose by 9.98% to $1.9 billion in 2022, then soared by 33.26% to $2.6 billion in 2023, then dropped by 2.6% to $2.5 billion in 2024, then increased by 4.91% to $2.6 billion in 2025.
  • Its Invested Capital was $2.6 billion in Q3 2025, compared to $2.1 billion in Q2 2025 and $2.0 billion in Q1 2025.